glp-1 in development History of Medications GLP-1-based therapies for diabetes, obesity

Qian Z, Chen H, Xia M, et al

Learn healthier habits through short, science-backed lessons designed to support lasting change

A recent study compared semaglutide and tirzepatide for weight loss and found that tirzepatide resulted in 2.4% more weight loss at 3 months, 4.3% more at 6 months, and 6.9% more at 12 months

Staying hydrated and sipping ginger tea or peppermint tea after meals promotes gentle digestive movement and may reduce gas accumulation

Theoretically, nanoparticles (NPs) encapsulating GLP-1RAs can significantly extend the drugs half-life and promote accumulation of the drug in the joint cartilage, thereby maintaining a high therapeutic concentration for an extended period and improving treatment efficacy